melanoma (skin)

Showing NaN - NaN of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma (Skin) Trial in Los Angeles (CP-675,206)

Completed
  • Melanoma (Skin)
  • CP-675,206
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Oct 1, 2020

Melanoma (Skin) Trial in Los Angeles (maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 mAb)

Completed
  • Melanoma (Skin)
  • maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Melanoma (Skin) Trial in Los Angeles (dendritic cell-MART-1 peptide vaccine)

Completed
  • Melanoma (Skin)
  • dendritic cell-MART-1 peptide vaccine
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Melanoma (Skin) Trial in Canada, United States (temsirolimus)

Completed
  • Melanoma (Skin)
  • Duarte, California
  • +20 more
Jun 3, 2015

Melanoma (Skin), Neuroblastoma, Sarcoma Trial in Australia, Canada, United States (hu14.18-IL2 fusion protein)

Completed
  • Melanoma (Skin)
  • +3 more
  • hu14.18-IL2 fusion protein
  • Little Rock, Arkansas
  • +58 more
Aug 6, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Terminated
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +4 more
  • Los Angeles, California
  • +1 more
May 20, 2014

Melanoma (Skin) Trial in Los Angeles, Ann Arbor (gp100 antigen, incomplete Freund's adjuvant, sargramostim)

Completed
  • Melanoma (Skin)
  • gp100 antigen
  • +3 more
  • Los Angeles, California
  • +1 more
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Duarte, Los Angeles (gp100 antigen, incomplete Freund's adjuvant, recombinant

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +3 more
  • Duarte, California
  • +1 more
May 20, 2014

Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, aldesleukin, gp100 antigen)

Terminated
  • Melanoma (Skin)
  • MART-1 antigen
  • +10 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (biological, drug, procedure)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +7 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +5 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles, Ann Arbor (MART-1 antigen, gp100:209-217(210M) peptide vaccine,

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +3 more
  • Los Angeles, California
  • +1 more
May 19, 2014

Melanoma (Skin) Trial in Los Angeles, Berkeley Heights (oblimersen sodium, dacarbazine)

Completed
  • Melanoma (Skin)
  • Los Angeles, California
  • +1 more
Jan 3, 2014

Melanoma (Skin) Trial in Los Angeles (oblimersen sodium, dacarbazine)

Unknown status
  • Melanoma (Skin)
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jan 3, 2014

Melanoma (Skin) Trial in Los Angeles (paclitaxel albumin-stabilized nanoparticle formulation)

Completed
  • Melanoma (Skin)
  • paclitaxel albumin-stabilized nanoparticle formulation
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Dec 18, 2013

Melanoma (Skin) Trial in Los Angeles (autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine)

Completed
  • Melanoma (Skin)
  • autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Nov 5, 2013

Bladder Cancer, Breast Cancer, Colorectal Cancer Trial in Los Angeles, New York (tanespimycin)

Completed
  • Bladder Cancer
  • +11 more
  • Los Angeles, California
  • +1 more
Jun 20, 2013

Melanoma (Skin) Trial in United States (recombinant interferon alfa, thalidomide)

Completed
  • Melanoma (Skin)
  • Mobile, Alabama
  • +93 more
Jun 20, 2013

Melanoma (Skin) Trial in United States (D1/3-MAGE-3-His fusion protein, SB-AS02B adjuvant)

Completed
  • Melanoma (Skin)
  • D1/3-MAGE-3-His fusion protein
  • SB-AS02B adjuvant
  • Tucson, Arizona
  • +6 more
Jun 21, 2013

Melanoma (Skin), Metastatic Cancer Trial in United States (stereotactic radiosurgery)

Terminated
  • Melanoma (Skin)
  • Metastatic Cancer
  • stereotactic radiosurgery
  • Mobile, Alabama
  • +85 more
Jan 30, 2013

Melanoma (Skin) Trial in United States (temozolomide, thalidomide)

Completed
  • Melanoma (Skin)
  • Anchorage, Alaska
  • +131 more
Aug 20, 2012

Melanoma (Skin) Trial in United States (vinorelbine)

Completed
  • Melanoma (Skin)
  • Mobile, Alabama
  • +85 more
Aug 20, 2012

Melanoma (Skin) Trial in Los Angeles (Synchrotope TA2M)

Completed
  • Melanoma (Skin)
  • Synchrotope TA2M
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
Jul 9, 2012

Melanoma (Skin) Trial in United States (MKC1106-MT)

Completed
  • Melanoma (Skin)
  • MKC1106-MT
  • Tucson, Arizona
  • +4 more
May 11, 2011

Melanoma (Skin) Trial in United States (aldesleukin, filgrastim, recombinant interferon alfa)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +5 more
  • Mobile, Alabama
  • +93 more
Jan 28, 2010